This is a routine capital increase from employee warrant exercises with negligible dilution (0.04%). No trading action warranted; monitor for any upcoming pipeline catalysts or financial results.
GMAB drugs
GMAB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 11 $30.85entry
- T+1 · 3mo ago +1.85%α +1.60% · $31.42
- T+5 · 3mo ago +6.84%α +7.24% · $32.96
- T+20 · 2mo ago +7.10%α +8.16% · $33.04
- T+60 · 13d ago +78.87%α +79.00% · $55.18
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Genmab filed a 6-K reporting a routine capital increase of 24,592 shares from employee warrant exercises, raising approximately DKK 37.9 million (0.04% of share capital). This is a standard administrative event with no material impact on the company's financial position or operations.
Key Facts
- Share capital increased by 24,592 shares due to employee warrant exercises.
- Proceeds to the company are approximately DKK 37.9 million.
- The increase represents approximately 0.04% of Genmab's total share capital.
- Total share capital post-increase is DKK 62,377,844 (62,377,844 shares).
Financial Impact
Proceeds of approximately DKK 37.9 million (0.04% of share capital), immaterial.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (GMAB), Batch item 1 | 0001434265-26-000111 |
| Document: gmab_20260811x6k.htm | 0001434265-26-000111 |
| Document: 0001434265-26-000111-index-headers.html | 0001434265-26-000111 |
| Document: 0001434265-26-000111-index.html | 0001434265-26-000111 |
| Document: 0001434265-26-000111.txt | 0001434265-26-000111 |
| 6-K Filing (GMAB), Batch item 6 | 0001434265-26-000111 |
| Document: gmab_20260811x6k.htm | 0001434265-26-000111 |
| Document: 0001434265-26-000111-index-headers.html | 0001434265-26-000111 |
| Document: 0001434265-26-000111-index.html | 0001434265-26-000111 |
| Document: 0001434265-26-000111.txt | 0001434265-26-000111 |
Track record
31 reports on GMAB
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $53.87 Now $51.57 −4.27% settles Dec 10
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $54.07 Now $51.57 −4.62% settles Dec 9
- Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers